JACC:LVEF降低的主动脉瓣狭窄患者预后更差

2018-03-26 MedSci MedSci原创

对于部分严重的主动脉瓣狭窄(AS)患者,其左室射血分数(LVEF)有所降低。本研究的目的旨在评估LVEF降低对严重AS患者预后的影响以及预测其的因素。本研究纳入了938例诊断为严重AS的患者,并对所有患者进行了一系列的心超检查,在随访的10年期间,共获得3684个(平均3个/患者)心超图像。分析结果发现,在最初的诊断中,有196例(21%)患者的LVEF<50% (35.1 ± 9.7%),对于这

对于部分严重的主动脉瓣狭窄(AS)患者,其左室射血分数(LVEF)有所降低。本研究的目的旨在评估LVEF降低对严重AS患者预后的影响以及预测其的因素。

本研究纳入了938例诊断为严重AS的患者,并对所有患者进行了一系列的心超检查,在随访的10年期间,共获得3684个(平均3个/患者)心超图像。分析结果发现,在最初的诊断中,有196例(21%)患者的LVEF<50% (35.1 ± 9.7%),对于这些诊断为AS之前LVEF就已经<50%的患者,其LVEF恶化速度更快,而最初LVEF≥50%的患者随访后的平均LVEF>60%,预测LVEF恶化的关联性最强的因子是诊断AS前3年患者的LVEF<60%(OR:0.86; 95% Cl: 0.83 - 0.89; p < 0.001)。在平均3.3年的随访时间里,与LVEF≥60%的患者相比,LVEF<60%患者的死亡率明显更高((p < 0.001)。

研究结果显示,在严重主动脉瓣狭窄患者中,诊断AS前LVEF就有所下降的患者预后更差,LVEF<60%患者的死亡率要更高。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1691972, encodeId=8cf116919e283, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Sat Dec 22 13:08:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853978, encodeId=928418539e824, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Nov 08 12:08:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325775, encodeId=7c351325e7561, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332507, encodeId=104c133250eef, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415292, encodeId=9d2a1415292c5, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552234, encodeId=6dc7155223423, content=<a href='/topic/show?id=d35711121eb' target=_blank style='color:#2F92EE;'>#LVEF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11121, encryptionId=d35711121eb, topicName=LVEF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908114270035, createdName=mhzhuang@stu.e, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1691972, encodeId=8cf116919e283, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Sat Dec 22 13:08:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853978, encodeId=928418539e824, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Nov 08 12:08:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325775, encodeId=7c351325e7561, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332507, encodeId=104c133250eef, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415292, encodeId=9d2a1415292c5, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552234, encodeId=6dc7155223423, content=<a href='/topic/show?id=d35711121eb' target=_blank style='color:#2F92EE;'>#LVEF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11121, encryptionId=d35711121eb, topicName=LVEF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908114270035, createdName=mhzhuang@stu.e, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
    2018-11-08 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1691972, encodeId=8cf116919e283, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Sat Dec 22 13:08:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853978, encodeId=928418539e824, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Nov 08 12:08:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325775, encodeId=7c351325e7561, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332507, encodeId=104c133250eef, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415292, encodeId=9d2a1415292c5, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552234, encodeId=6dc7155223423, content=<a href='/topic/show?id=d35711121eb' target=_blank style='color:#2F92EE;'>#LVEF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11121, encryptionId=d35711121eb, topicName=LVEF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908114270035, createdName=mhzhuang@stu.e, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1691972, encodeId=8cf116919e283, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Sat Dec 22 13:08:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853978, encodeId=928418539e824, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Nov 08 12:08:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325775, encodeId=7c351325e7561, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332507, encodeId=104c133250eef, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415292, encodeId=9d2a1415292c5, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552234, encodeId=6dc7155223423, content=<a href='/topic/show?id=d35711121eb' target=_blank style='color:#2F92EE;'>#LVEF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11121, encryptionId=d35711121eb, topicName=LVEF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908114270035, createdName=mhzhuang@stu.e, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1691972, encodeId=8cf116919e283, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Sat Dec 22 13:08:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853978, encodeId=928418539e824, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Nov 08 12:08:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325775, encodeId=7c351325e7561, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332507, encodeId=104c133250eef, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415292, encodeId=9d2a1415292c5, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552234, encodeId=6dc7155223423, content=<a href='/topic/show?id=d35711121eb' target=_blank style='color:#2F92EE;'>#LVEF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11121, encryptionId=d35711121eb, topicName=LVEF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908114270035, createdName=mhzhuang@stu.e, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1691972, encodeId=8cf116919e283, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Sat Dec 22 13:08:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853978, encodeId=928418539e824, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Nov 08 12:08:00 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325775, encodeId=7c351325e7561, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332507, encodeId=104c133250eef, content=<a href='/topic/show?id=1dd6231822d' target=_blank style='color:#2F92EE;'>#主动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23182, encryptionId=1dd6231822d, topicName=主动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415292, encodeId=9d2a1415292c5, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552234, encodeId=6dc7155223423, content=<a href='/topic/show?id=d35711121eb' target=_blank style='color:#2F92EE;'>#LVEF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11121, encryptionId=d35711121eb, topicName=LVEF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908114270035, createdName=mhzhuang@stu.e, createdTime=Wed Mar 28 00:08:00 CST 2018, time=2018-03-28, status=1, ipAttribution=)]

相关资讯

Stroke:PPI与噻吩并吡啶

关于PPI和噻吩并吡啶交互作用的大部分研究多聚焦心血管事件,仅几项研究报道了脑血管事件。个别研究未能确定氯吡格雷联合PPI对缺血性卒中的影响。此外,由于缺乏证据(矛盾的结果),缺乏一致性意见,PPI联合噻吩并吡啶啶啶是临床的一道谜题。

CIT 2018:QFR在患者水平诊断精度荟萃分析结果首发

3月24日上午,在CIT2018 PCR at CIT专场,丹麦奥胡思大学医院(Aarhus University Hospital)Niels Holm博士首次发布“定量血流分数的诊断精度-一项来自四个前瞻性多中心临床研究的患者水平荟萃分析”。这不仅意味着国际心血管领域对QFR临床价值的认可,也意味着QFR推向临床应用又迈出了坚实的一步。

CIT 2018:新时代、新征程:从心脏介入治疗到心血管病整体防控

3月23日上午,第十六届中国介入心脏病学大会(CIT2018)开幕式和全体大会在苏州金鸡湖国际会议中心隆重召开。全球介入心脏病学意见领袖共聚一堂,由精彩示教演示、重磅研究解读、基于案例的临床热点议题讨论等组成的全体大会为大家奉上一场学术的饕餮盛宴。

JACC:心超技术员在心脏介入手术中暴露的辐射剂量问题不容忽视!

经食道超声技术员(TEEOP)可以为心脏介入手术患者提供必要的临床影像资料,他们的位置往往靠近患者,并且会收到一些散在的辐射。本研究的目的旨在评估TEEOP在心脏介入手术中收到的辐射剂量。本研究对关键相关人员(TEEOP、麻醉师、主刀和二助)在做经食道超声检查时佩戴可卸载的辐射检测仪,对TEEOP的有效剂量(E)和E/KAP进行了测量。分析结构发现,在最开始的98次操作中,TEEOP的平均E值为2

JACC:LFLG主动脉瓣狭窄患者瓣膜置换术后的预后研究

近日,在国际心血管权威杂志JACC上发表了一篇临床研究,旨在评估低流量低压差主动脉瓣狭窄(LFLG-AS)患者经皮主动脉瓣置换术(TAVR)后的临床预后及左室射血分数(LVEF)的变化。本研究纳入了多中心数据库中287例接受有TAVR治疗的LFLG-AS患者,其中有234例患者在术前接受了多巴酚丁胺负荷超声心动图(DSE)检查,在患者出院时和随访1年后对所有患者进行了经胸超声心动图检查。分析结果发

Sci China Life Sci:国人保持7项心血管健康指标可预防62%心血管病

近日,《中国科学:生命科学》英文版在线发表了中国医学科学院阜外医院顾东风院士团队研究成果:我国20岁以上成年人中,约62%的冠心病和脑卒中的发生,归因于没有达到7项理想的心血管健康指标。